Impact of incomplete revascularization in patients undergoing PCI for unprotected left main stem stenosis

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 6, 2013, Pages 939-946

  Malkin, Chris J ^a   Ghobrial, Mina S A ^a   Raina, Tushar ^a   Siotia, Anjan ^a   Morton, Allison C ^a,b   Gunn, Julian ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

angioplasty; left main PCI; revascularization; stents; survival; SYNTAX score

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FOLLOW UP; HEART HEMODYNAMICS; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; REVASCULARIZATION; SURVIVAL RATE; SYNTAX SCORE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876461935     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24695     Document Type: Article

References (33)

1. Kappetein, AP, Feldman TE, Mack MJ, Morice M-C, Holmes DR, Stahle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A,. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 32: 2125-2134.
2. Rastan, AJ, Boudriot E, Falk V, Kappetein AP, Borger MA, Serruys PW, Schuler G, Mohr FW,. Frequency and pattern of de-novo three-vessel and left main coronary artery disease; insights from single center enrolment in the SYNTAX study. Eur J Cardiothorac Surg 2008; 34: 376-382; discussion 382-383.
3. Chieffo, A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G, Sangiorgi G, Alfieri O, Colombo A,. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience. Circulation 2006; 113: 2542-2547.
4. Buszman, PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M, Wallace-Bradley D, Wilczynski M, Banasiewicz-Szkrobka I, Peszek-Przybyla E, Krol M, Kondys M, Milewski K, Wiernek S, Debinski M, Zurakowski A, Martin JL, Tendera M,. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am Coll Cardiol 2009; 54: 1500-1511.
5. Sanmartin, M, Baz JA, Claro R, Asorey V, Duran D, Pradas G, Iniguez A,. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 2007; 100: 970-973.
6. Seung, KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ,. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781-1792.
7. Kleisli, T, Cheng W, Jacobs MJ, Mirocha J, Derobertis MA, Kass RM, Blanche C, Fontana GP, Raissi SS, Magliato KE, Trento A,. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2005; 129: 1283-1291.
8. Kozower, BD, Moon MR, Barner HB, Moazami N, Lawton JS, Pasque MK, Damiano RJ Jr,. Impact of complete revascularization on long-term survival after coronary artery bypass grafting in octogenarians. Ann Thorac Surg 2005; 80: 112-116; discussion 116-117.
9. Osswald, BR, Blackstone EH, Tochtermann U, Schweiger P, Thomas G, Vahl CF, Hagl S,. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? Eur J Cardiothorac Surg 2001; 20: 120-125, discussion 125-126.
10. Migliorini, A, Valenti R, Parodi G, Buonamici P, Cerisano G, Carrabba N, Vergara R, Antoniucci D,. The impact of right coronary artery chronic total occlusion on clinical outcome of patients undergoing percutaneous coronary intervention for unprotected left main disease. J Am College Cardiol 2011; 58: 125-130.
11. Serruys, PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW,. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
12. Berger JS, Petersen JL, Brown DL,. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in new york state / clinical perspective. Circulation: Cardiovascular Interv 2009; 2: 317-322.
13. Yan, L-q, Guo L-j, Zhang F-c, and, Gao W,. The relationship between kidney function and angiographically-derived SYNTAX score. Can J Cardiol 2011; 27: 768-772.
14. Wu, C, Hannan EL, Walford G, Ambrose JA, Holmes DR Jr, King SB, 3rd, Clark LT, Katz S, Sharma S, Jones RH,. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 2006; 47: 654-660.
15. Romagnoli, E, Burzotta F, Trani C, Siviglia M, Biondi-Zoccai GG, Niccoli G, Leone AM, Porto I, Mazzari MA, Mongiardo R, Rebuzzi AG, Schiavoni G, Crea F,. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 2009; 95: 43-48.
16. Cutlip, DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW,. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
17. Kunadian, B, Dunning J, Roberts AP, Morley R, Twomey D, Hall JA, Sutton AG, Wright RA, Muir DF, de Belder MA,. Cumulative funnel plots for the early detection of interoperator variation: Retrospective database analysis of observed versus predicted results of percutaneous coronary intervention. BMJ 2008; 336: 931-934.
18. Spiegelhalter, DJ,. Funnel plots for comparing institutional performance. Stat Med 2005; 24: 1185-1202.
19. Rodes-Cabau, J, DeBlois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais Fo, Dry J-P, Mathieu P, Rousseau M, Barbeau GR, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochelliere R, Bogaty P, Voisine P,. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008; 118: 2374-2381.
20. Wood, FO, Saylors EK, Schneider JE, Jobe RL, Mann JT III,. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk. Catheter Cardiovasc Interv 2008; 71: 533-538.
21. Valgimigli, M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G,. Cyphering the complexity of coronary artery disease using the SYNTAX score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007; 99: 1072-1081.
22. Capodanno, D, Di Salvo ME, Cincotta G, Miano M, Tamburino C,. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circulation Cardiovascular Interv 2009; 2: 302-308.
23. Garg, S, Sarno G, Girasis C, Vranckx P, de Vries T, Swart M, Bressers M, Garcia-Garcia HM, van Es GA, Raber L, Campo G, Valgimigli M, Dawkins KD, Windecker S, Serruys PW,. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC. Cardiovascular Interv 2011; 4: 645-653.
24. Wykrzykowska, JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW,. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am College Cardiol 2010; 56: 272-277.
25. Brener, SJ, Prasad AJ, Abdula R, Sacchi TJ,. Relationship between the angiographically derived SYNTAX score and outcomes in high-risk patients undergoing percutaneous coronary intervention. J Invasive Cardiol 2011; 23: 66-69.
26. Garg, S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S,. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the RESOLUTE All Comers Trial. JACC. Cardiovascular Interv 2011; 4: 432-441.
27. Capodanno, D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, Sanfilippo A, Capranzano P, Tamburino C,. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 2010; 159: 103-109.
28. Kim, Y-H, Park D-W, Kim W-J, Lee J-Y, Yun S-C, Kang S-J, Lee S-W, Lee CW, Park S-W, Park S-J,. Validation of SYNTAX (synergy between PCI with taxus and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC: Cardiovascular Interv 2010; 3: 612-623.
29. Capodanno, D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C,. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovascular Interv 2011; 4: 287-297.
30. Chen, S-L, Chen JP, Mintz G, Xu B, Kan J, Ye F, Zhang J, Sun X, Xu Y, Jiang Q, Zhang A, Stone GW,. Comparison between the NERS (new risk stratification) Score and the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score in outcome prediction for unprotected left main stenting. JACC: Cardiovascular Interv 2010; 3: 632-641.
31. Garg, S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW, Investigators obotA-I. A new tool for the risk stratification of patients with complex coronary artery disease / clinical perspective. Circulation: Cardiovascular Interv 2010; 3: 317-326.
32. Girasis, C, Garg S, Raber L, Sarno G, Morel MA, Garcia-Garcia HM, Luscher TF, Serruys PW, Windecker S,. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: A substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 2011; 32: 3115-3127.
33. Genereux, P, Palmerini T, Caixeta A, Rosner G, Green P, Dressler O, Xu K, Parise H, Mehran R, Serruys PW, Stone GW,. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am College Cardiol 2012; 59: 2165-2174.